This inventor holds 1 USPTO granted patent. Top assignees: Amgen Fremont Inc., Celldex Therapeutics Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 78 
1 out of 45 
Years Active: 2014
Title: Feng Xiao: Innovator in Antibody Development
Introduction
Feng Xiao is a prominent inventor based in Union City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies.
Latest Patents
Feng Xiao holds a patent titled "Antibodies directed to GPNMB and uses thereof." This invention provides fully human monoclonal antibodies that specifically bind to GPNMB, along with their various applications. The patent includes nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules. It also details immunoconjugates that incorporate anti-GPNMB antibodies and methods for utilizing these immunoconjugates. Furthermore, the invention presents bi-specific antibodies that combine an anti-GPNMB antibody component with an anti-CD3 component, along with methods for their application.
Career Highlights
Throughout his career, Feng Xiao has worked with notable companies in the biotechnology sector, including Celldex Therapeutics Limited and Amgen Fremont Inc. His work has contributed to advancements in therapeutic antibody development.
Collaborations
Feng has collaborated with esteemed colleagues such as Xiao-Chi Jia and Meina Liang, enhancing the impact of his research and innovations.
Conclusion
Feng Xiao's contributions to the field of antibody development exemplify the innovative spirit of modern biotechnology. His work continues to influence advancements in medical treatments and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile